65,437 trials
Seasonal Affective Disorder
Primary: Percentage Change SIGH SAD Depression Rating — -36.4; -52.7 percentage of change on SIGH SAD — p=0.014
Seasonal Affective Disorder
Primary: Percentage SIGH SAD (Structured Interview Guide For The Hamilton Depression Rating Scale), SAD Version — 34.5; 60.4 Percentage of SIGH SAD — p=0.028
Myelodysplastic Syndrome · Aplastic Anemia
Primary: Overall Response — 8; 8; 4 participants
Endothelial Dysfunction
Primary: Absolute Change in Brachial Artery Flow-mediated Dilation at Day 7 From Day 0 — 4.08; 2.77; 2.97; 2.66 % of preocclusion diameter
Atrial Fibrillation
Primary: Number of Participants With Major (Per International Society on Thrombosis and Haemostasis [ISTH] Criteria) or Clinically Relevant Non-major Bleeding Adjudicated by…
Kidney Cancer
Primary: Progression Free Survival (PFS), the Length of Time, in Months, That Patients Were Alive From Their First Date of Protocol Treatment Until Worsening of Their Disease…
Refractory Multiple Myeloma · Stage I Multiple Myeloma · Stage II Multiple Myeloma
Primary: The Number of Confirmed Responses (Complete Response [CR], Very Good Partial Response [VGPR], or Partial Response [PR]) — 0 participants
Type 2 Diabetes · Diabetes
Primary: Change in Fasting Plasma Glucose Concentration — 4.7; 0.0 mmol/l
Drug Dependence · Alcohol Dependence
Primary: Hopkins Verbal Learning Test (HVLT) Total Recall — 17.27; 18.00; 15.27; 17.50 units on a scale
Burns
Primary: Total Number of Blood Components Transfused During and up to 24 Hours Post Operatively — 68.9; 87.2; 0; 4.1 units of blood components
Coronary Arteriosclerosis
Primary: Major Cardiac Adverse Events (Including Cardiac Death, Myocardial Infarction (Q-wave and Non Q-wave) and Clinically Driven TLR (Target Lesion Revascularization)) — 9…
Schizophrenia
Primary: Change From Baseline in Insulin Sensitivity — 3.2; 0.4 microUnits/mL — p=0.08
Prostate Cancer
Primary: Skeletal-related Event-free Survival in Men With Bone Metastases From Prostate Cancer — 58; 49; 201; 214 participants
Allergic Conjunctivitis
Primary: Mean Change From Baseline in Staff-Assessed Ocular Redness, Area Under the Curve From Time Zero to Hour 10 [AUC (0-10)], Maxidex and Placebo — 18.120; 19.362; 16.823…
Systemic Arterial Hypertension · Hypertension Resistant to Conventional Therapy · Myocardial Infarction
Primary: Strokes, Either Fatal or Nonfatal — 24; 7 participants — p=0.19